tirzepatide fda lawsuit The says the Zepbound shortage is over. That's rattling the weight loss industry Oral Tirzepatide Class Action Lawsuit

In chronic kidney disease, the pivotal FLOW trial demonstrated that semaglutide 1 mg reduced the risk of major kidney events by 24% in patients with type 2 diabetes and CKD, resulting in a dedicated indication in this population

The active ingredient is tirzepatide

All their cardiometabolic markers, including blood glucose levels, blood pressure and cholesterol, also reversed

Product Specifications Compound: Retatrutide Quantity: 10mg per vial Format: Lyophilized powder Grade: Research use only Purity: High-purity research material Packaging: Sealed sterile research vial Handling & Storage Refrigeration between 28C recommended for optimal long-term stability Store away from heat, moisture, and direct light Keep vial sealed until use in laboratory settings Avoid repeated freeze/thaw cycles after reconstitution Quality & Research Standards Each batch is handled under controlled processing conditions to support product consistency and research reliability

This medication is not yet FDA approved but is showing promising results in clinical trials